LIAISON Treponema Screen - Treponema pallidum total antibody IVD, kit, chemiluminescent immunoassay

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Available from:

DiaSorin Australia Pty Ltd

Class:

Class 4

Manufactured by:

DiaSorin Italia SpA Via Crescentino snc, Saluggia VC, 13040 Italy

Therapeutic area:

59863 - Treponema pallidum total antibody IVD, kit, chemiluminescent immunoassay

Therapeutic indications:

The method for determination of specific total antibodies to Treponema pallidum is a one-step sandwich chemiluminescence immunoassay (CLIA). The LIAISON? Treponema Screen assay uses chemiluminescent immunoassay (CLIA) technology for the qualitative determination of specific total antibodies to Treponema pallidum in human serum or plasma samples including post-mortem specimens, collected up to 24 hours after death. The test has to be performed on the LIAISON? Analyzer family.

Authorization status:

A

Authorization date:

2018-10-24